mesoblast Global Leader in Allogeneic Cellular Medicines for Inflammatory Diseases August 2023 ASX: MSB; Nasdaq: MESO Financial Results and Operational Update for the Year Ended June 30, 2023 CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS This presentation includes forward-looking statements that relate to future events or our future financial performance and involve known and unknown risks, uncertainties and other factors that may cause our actual results, levels of activity, performance or achieveme ...